GlassScriptPhysician profile
Pallavi Gupta
NPI 1043503824
$7,516.40
in general payments reported to CMS, 2019-2025
47 companies · $870 in 2025
The $870 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $916 · 2020: $520 · 2021: $2,250 · 2022: $388 · 2023: $1,105 · 2024: $1,469 · 2025: $870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,408 · Travel and Lodging: $35.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,407.78 |
| Travel and Lodging | $35.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,495.64 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Nevro Corp. | $951.99 | 2019-2024 | Senza |
| Abbott Laboratories | $528.84 | 2019-2023 | Eterna, Proclaim |
| Saluda Medical Americas, INC. | $413.16 | 2023-2025 | Evoke, Evoke Scs |
| Biotronik Nro, INC. | $304.83 | 2024-2025 | Prospera |
| Forte Bio-Pharma LLC | $268.64 | 2020-2024 | Prolate, Nalocet |
| Collegium Pharmaceutical, INC. | $231.19 | 2020-2025 | Xtampza |
| Biodelivery Sciences International, INC. | $207.82 | 2019-2021 | |
| Stryker Corporation | $205.71 | 2019-2024 | Mild Device Kit |
| Stimwave Technologies Incorporated | $153.79 | 2019-2022 | |
| Pacira Therapeutics, INC. | $129.29 | 2019-2021 | |
| Spr Therapeutics, INC | $120.59 | 2021 | |
| Si-Bone, INC. | $109.30 | 2025 | |
| Medtronic, INC. | $108.21 | 2023-2024 | Intellis Adaptivestim |
| Almatica Pharma LLC | $100.62 | 2021 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $98.03 | 2020 | |
| Pfizer INC. | $97.95 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $97.63 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $82.45 | 2019-2025 | Relistor |
| Sentynl Therapeutics, INC. | $64.90 | 2019 | |
| Daiichi Sankyo INC. | $59.06 | 2019 | |
| Azurity Pharmaceuticals, INC. | $52.04 | 2023-2025 | Horizant, Horizant |
| Curonix LLC | $48.63 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Averitas Pharma INC. | $47.40 | 2023-2024 | Qutenza |
| Virtus Pharmaceuticals LLC | $45.08 | 2021-2025 | Levorphanol Tartrate |
| Trevena, INC. | $41.74 | 2022-2023 | Olinvyk |
| Depuy Synthes Sales INC. | $39.64 | 2019 | |
| Scilex Pharmaceuticals INC. | $38.73 | 2019-2021 | |
| Assertio Therapeutics, INC. | $30.28 | 2019 | |
| Zyla Life Sciences, INC. | $27.82 | 2019 | |
| Bioventus LLC | $26.24 | 2022 | |
| Foundation Fusion Solutions, LLC | $25.22 | 2025 | |
| Masimo Corporation | $24.88 | 2023 | Patient Safetynet System |
| Medtronic USA, INC. | $23.74 | 2019-2020 | |
| Flowonix Medical Incorporated | $22.15 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $22.03 | 2025 | Iovera, Zilretta |
| Acacia Pharma INC | $19.53 | 2022 | |
| Horizon Therapeutics Plc | $18.74 | 2021 | |
| Merz Pharmaceuticals, LLC | $18.63 | 2021 | |
| Baudax Bio INC. | $17.94 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $17.92 | 2023 | Seglentis |
| Atland Pharmaceuticals, LLC | $15.19 | 2025 | Tolmetin Sodium, Orphenadrine Citrate, Aspirin and Caffeine |
| Relievant Medsystems, INC. | $14.06 | 2021 | |
| Vertiflex, INC. | $13.22 | 2019 | |
| Amgen INC. | $12.22 | 2021 | |
| Kaleo, INC. | $12.06 | 2019 | |
| Tersera Therapeutics LLC | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pallavi Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.